Rare Diseases Report 2022

NORD Rare Disease Centers of Excellence: A new network seeks to break down barriers in rare disease care


 

On the intranet, we will also have a growing set of useful databases, links, and documents that are available to all members. These will be progressively updated with help from experts at the centers, so that clinicians can more directly learn from each other, instead of separately reinventing the wheel. The way things usually work, when you see a patient with an ultrarare condition that you’re not that familiar with, is that you tell them what little you can, then schedule them to come back in a few weeks. In the meantime, usually in your off time, you spend hours searching PubMed and other sources and you try to piece things together, to figure out what’s known that might help your patient. But imagine that this has already been figured out by someone else in the network. You can see on the network a list of articles the other expert read and found helpful in addressing this problem. And you then reach out directly to that other expert.

In recent months you’ve had one-on-one meetings with all 31 directors at the sites, and after that you convened 11 working groups. What are you trying to achieve?

Once the sites were chosen, we aimed to talk quickly and honestly about what everyone needed, what everyone saw as the biggest problems to tackle in rare diseases. Two things were very rewarding about those phone calls: one, all the centers were very enthusiastic, and two, they pretty much all agreed on what the key unmet needs are for rare disease patients and the practitioners trying to help them. So, we empaneled working groups of expert volunteers enthusiastic to work on each of those problems. These groups collectively comprise more than 200 volunteers – faculty, staff, and trainees – from the different sites nationwide. Each group is working on a key unmet need in rare diseases, and each group will be given its own space on our file-sharing platform, where they can share information and co-develop new ideas and documents. When something they produce is good enough to start to be a practice resource, such as a draft treatment guideline that the working group now wants to try in the real world, but it’s not yet ready to be published, they can share it and have it tested by all 31 sites through the dedicated intranet we are building for the network.

Jennie Smith is a freelance journalist specializing in medicine and health.

Pages

Recommended Reading

Focal Palmoplantar Keratoderma and Gingival Keratosis Caused by a KRT16 Mutation
MDedge Dermatology
Topical gene therapy for dystrophic epidermolysis bullosa shows promise
MDedge Dermatology
Peristomal Pyoderma Gangrenosum at an Ileostomy Site
MDedge Dermatology
Ustekinumab becomes second biologic approved for PsA in kids
MDedge Dermatology
Biosimilar-to-biosimilar switches deemed safe and effective, systematic review reveals
MDedge Dermatology
Exaggerated Facial Lines on the Forehead and Cheeks
MDedge Dermatology
FDA okays spesolimab, first treatment for generalized pustular psoriasis
MDedge Dermatology
Uncombable hair syndrome: One gene, variants responsible for many cases
MDedge Dermatology
IVIG proves effective for dermatomyositis in phase 3 trial
MDedge Dermatology
Combination of energy-based treatments found to improve Becker’s nevi
MDedge Dermatology